|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Magenta Therapeutics Inc. (MGTA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-09-19 Sale |
2019-09-19 4:26 pm |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
1,656 | $12 | $19,872 | 263,023 (Direct) |
View |
| 2019-09-12 Sale |
2019-09-16 6:36 pm |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
844 | $12 | $10,128 | 264,679 (Direct) |
View |
| 2019-09-03 Sale |
2019-09-04 5:06 pm |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
5,000 | $10.11 | $50,531 | 265,523 (Direct) |
View |
| 2019-08-01 Sale |
2019-08-01 4:14 pm |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
7,500 | $13.42 | $100,631 | 273,023 (Direct) |
View |
| 2019-07-01 Sale |
2019-07-02 10:51 am |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
7,500 | $14.4 | $107,983 | 280,523 (Direct) |
View |
| 2019-06-21 Sale |
2019-06-24 4:02 pm |
Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer |
5,415 | $16.07 | $87,019 | 98,116 (Direct) |
View |
| 2019-06-20 Sale |
2019-06-24 4:02 pm |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director |
14,000 | $15.11 | $211,523 | 361,543 (Indirect Direct) |
View |
| 2019-06-17 Sale |
2019-06-18 5:18 pm |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
7,500 | $13.9 | $104,267 | 285,523 (Direct) |
View |
| 2019-03-20 Sale |
2019-03-22 5:03 pm |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
14,245 | $17.86 | $254,416 | 4,117,125 (Indirect Direct) |
View |
| 2019-03-20 Sale |
2019-03-22 5:01 pm |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
14,245 | $17.86 | $254,416 | 4,117,125 (Indirect) |
View |
| 2018-06-25 Purchase |
2018-06-27 4:36 pm |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
6,600 | $15 | $99,000 | 580,499 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-20 Option Award |
2019-06-24 5:04 pm |
N/A 2029-06-19 |
Magenta Therapeutics Inc. | MGTA | McGeorge Anne Director |
36,377 | $14.94 | 36,377 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:13 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:13 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:12 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:07 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:06 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:03 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | BYERS BLAKE Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 5:00 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | Borisy Alexis Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-06-07 Option Award |
2019-06-11 4:59 pm |
N/A 2029-06-06 |
Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director |
18,188 | $13.4 | 18,188 (Direct) |
View |
| 2019-03-20 Other |
2019-03-22 5:03 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
726,500 | $0 | 4,117,125 (Direct) |
View |
| 2019-03-20 Other |
2019-03-22 5:03 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
14,245 | $0 | 4,117,125 (Indirect) |
View |
| 2019-03-20 Other |
2019-03-22 5:01 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
726,500 | $0 | 4,117,125 (Indirect) |
View |
| 2019-03-20 Other |
2019-03-22 5:01 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
14,245 | $0 | 4,117,125 (Indirect) |
View |
| 2019-02-05 Option Award |
2019-02-07 4:23 pm |
N/A 2029-02-04 |
Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks |
80,000 | $7.13 | 80,000 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-07 4:20 pm |
N/A 2029-02-04 |
Magenta Therapeutics Inc. | MGTA | DAVIS JOHN C. JR Chief Medical Officer |
70,000 | $7.13 | 70,000 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-07 4:19 pm |
N/A 2029-02-04 |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
64,000 | $7.13 | 64,000 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-07 4:18 pm |
N/A 2029-02-04 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON Director |
182,900 | $7.13 | 182,900 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-07 4:16 pm |
N/A 2029-02-04 |
Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer |
80,000 | $7.13 | 80,000 (Direct) |
View |
| 2019-01-02 Option Award |
2019-01-04 4:16 pm |
N/A 2029-01-01 |
Magenta Therapeutics Inc. | MGTA | Ryan Jason See Remarks |
329,379 | $6 | 329,379 (Direct) |
View |
| 2018-09-25 Option Award |
2018-09-27 4:15 pm |
N/A 2028-09-24 |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
52,244 | $11.67 | 52,244 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
4,746,876 | $0 | 4,843,625 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
12,061,496 | $0 | 4,843,625 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner |
204,339 | $0 | 4,843,625 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
28,076 | $0 | 580,499 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
50,025 | $0 | 580,499 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
6,429 | $0 | 580,499 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:36 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Scadden David Director |
16,094 | $0 | 580,499 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
7,911,455 | $0 | 8,008,204 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
20,102,478 | $0 | 8,008,204 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
340,566 | $0 | 8,008,204 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
24,527 | $0 | 101,926 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
33,350 | $0 | 101,926 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:34 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director |
30,028 | $0 | 101,926 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:31 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
593,611 | $0 | 593,611 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:31 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
1,287,100 | $0 | 593,611 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:31 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director |
246,781 | $0 | 593,611 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
4,370 | $0 | 293,023 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
10,005 | $0 | 293,023 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | COOKE MICHAEL P. Chief Scientific Officer |
1,287 | $0 | 293,023 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks |
4,643 | $0 | 140,092 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | ZDRAVESKI ZORAN See Remarks |
12,000 | $0 | 140,092 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer |
2,912 | $0 | 103,531 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer |
6,670 | $0 | 103,531 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:30 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | ISACSON CHRISTINA K. Chief Business Officer |
857 | $0 | 103,531 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. Alphabet Inc. 10% Owner |
3,339,137 | $0 | 3,339,137 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. Alphabet Inc. 10% Owner |
133,400 | $0 | 3,339,137 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. Alphabet Inc. 10% Owner |
8,494,864 | $0 | 3,339,137 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
4,746,876 | $0 | 4,843,625 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
12,061,496 | $0 | 4,843,625 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:28 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Booth Bruce Director |
204,339 | $0 | 4,843,625 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director |
21,847 | $0 | 215,346 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director |
50,025 | $0 | 215,346 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BONNEY MICHAEL W Director |
6,429 | $0 | 215,346 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
4,152 | $0 | 4,152 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:27 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director |
10,729 | $0 | 4,152 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:25 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BYERS BLAKE Director |
3,339,137 | $0 | 3,339,137 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:25 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BYERS BLAKE Director |
133,400 | $0 | 3,339,137 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:25 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | BYERS BLAKE Director |
8,494,864 | $0 | 3,339,137 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 20 Sep 2019 05:54:29 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |